Corebridge Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,577	Closed	-$57.1K	–	2144
2025 Q1	$57.1K	Sell	1,577 -60	-4%	-$2.17K	﹤0.01%	2688
2024 Q4	$68.9K	Sell	1,637 -94	-5%	-$3.96K	﹤0.01%	2726
2024 Q3	$96.2K	Sell	1,731 -5	-0.3%	-$278	﹤0.01%	2634
2024 Q2	$71.4K	Buy	+1,736	New	+$71.4K	﹤0.01%	2775